Matches in DBpedia 2016-04 for { ?s ?p "Alexion Pharmaceuticals Inc. is an American pharmaceutical company best known for its development of Soliris, a drug used to treat the rare disorders atypical hemolytic uremic syndrome (aHUS) and paroxysmal nocturnal hemoglobinuria (PNH). The company is also involved in immune system research related to autoimmune diseases. It employs about 2,400 people worldwide. In 2016, The company will open its brand-new headquarters in New Haven, CT; not too far from where the company got its start."@en }
Showing triples 1 to 4 of
4
with 100 triples per page.
- Alexion_Pharmaceuticals abstract "Alexion Pharmaceuticals Inc. is an American pharmaceutical company best known for its development of Soliris, a drug used to treat the rare disorders atypical hemolytic uremic syndrome (aHUS) and paroxysmal nocturnal hemoglobinuria (PNH). The company is also involved in immune system research related to autoimmune diseases. It employs about 2,400 people worldwide. In 2016, The company will open its brand-new headquarters in New Haven, CT; not too far from where the company got its start.".
- Q204727 abstract "Alexion Pharmaceuticals Inc. is an American pharmaceutical company best known for its development of Soliris, a drug used to treat the rare disorders atypical hemolytic uremic syndrome (aHUS) and paroxysmal nocturnal hemoglobinuria (PNH). The company is also involved in immune system research related to autoimmune diseases. It employs about 2,400 people worldwide. In 2016, The company will open its brand-new headquarters in New Haven, CT; not too far from where the company got its start.".
- Alexion_Pharmaceuticals comment "Alexion Pharmaceuticals Inc. is an American pharmaceutical company best known for its development of Soliris, a drug used to treat the rare disorders atypical hemolytic uremic syndrome (aHUS) and paroxysmal nocturnal hemoglobinuria (PNH). The company is also involved in immune system research related to autoimmune diseases. It employs about 2,400 people worldwide. In 2016, The company will open its brand-new headquarters in New Haven, CT; not too far from where the company got its start.".
- Q204727 comment "Alexion Pharmaceuticals Inc. is an American pharmaceutical company best known for its development of Soliris, a drug used to treat the rare disorders atypical hemolytic uremic syndrome (aHUS) and paroxysmal nocturnal hemoglobinuria (PNH). The company is also involved in immune system research related to autoimmune diseases. It employs about 2,400 people worldwide. In 2016, The company will open its brand-new headquarters in New Haven, CT; not too far from where the company got its start.".